ICCM Short Volume

IceCure Medical Ltd (ICCM) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $5.2M, listed on NASDAQ, employing roughly 68 people, carrying a beta of 0.47 to the broader market. Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Led by Eyal Shamir, public since 2021-08-26.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date
2026-08-28
Short Volume
17.6K
Total Volume
35.4K
Short %
49.65%
30-Day Avg Short %
42.47%

Showing 30 days of FINRA short volume data for IceCure Medical Ltd.

Learn how short volume is reported and how to read the data →

Frequently asked ICCM short volume questions

What is the daily ICCM short volume?
As of Aug 28, 2026, IceCure Medical Ltd (ICCM) short volume is 17.6K shares against 35.4K total reported volume, or 49.65% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
How is ICCM short volume reported?
FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
What does ICCM short volume tell options traders?
Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.